false
0001058307
0001058307
2023-10-12
2023-10-12
0001058307
nxpl:CommonStockParValue00001CustomMember
2023-10-12
2023-10-12
0001058307
nxpl:WarrantsCustomMember
2023-10-12
2023-10-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 12, 2023
NEXTPLAT CORP
(Exact Name of Registrant as Specified in its Charter)
Nevada
|
|
001-40447
|
|
65-0783722
|
(State or Other Jurisdiction
of Incorporation or Organization)
|
|
(Commission
File No.)
|
|
(I.R.S. Employer
Identification No.)
|
3250 Mary St., Suite 410
Coconut Grove, FL 33133
(Address of principal executive offices and zip code)
(305) 560-5355
(Registrant’s telephone number, including area code)
(Former name or former address, if changed from last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol (s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.0001
|
|
NXPL
|
|
The Nasdaq Stock Market, Inc.
|
Warrants
|
|
NXPLW
|
|
The Nasdaq Stock Market, Inc.
|
Item 1.01 Entry into a Material Definitive Agreement.
As previously disclosed, on October 12, 2023, NextPlat Corp (the "Company") entered into a Distribution Agreement with OPKO HEALTH Spain, S.L.U. (“OPKO”) to market and resell certain OPKO health and veterinary products (the "Products") through the Alibaba platform in China (the "Distribution Agreement"). Under the Distribution Agreement, the Company was appointed as OPKO's exclusive distributor in China with respect to the Products. The Distribution Agreement has a term of one year and automatically renews for additional one-year terms unless either party provides ninety days prior written notice of non-renewal.
The foregoing description of the Distribution Agreement is not complete and is qualified in its entirety by reference to the Distribution Agreement, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
Exhibits.
+ The schedules to this exhibit have been redacted pursuant to Item 601(b)(10) of Regulation S-K. The Company hereby undertakes to furnish to the Securities and Exchange Commission an unredacted copy of the exhibit upon request by the Commission.
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
NEXTPLAT CORP
|
|
|
|
|
By:
|
/s/ Charles M. Fernandez
|
|
Name:
|
Charles M. Fernandez
|
|
Title:
|
Chairman and Chief Executive Officer
|
|
|
|
Dated: October 18, 2023
|
|
|